aTyr Pharma | LIFE - Equity Capital And Reserves

Stock Price
0.83
Daily Change
-0.05 -5.66%
Monthly
-20.75%
Yearly
-78.33%
Q1 Forecast
0.82

aTyr Pharma reported $80.24M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Ardelyx USD 154.28M 14.75M Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Galapagos EUR 3.24B 788.91M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
United Therapeutics USD 7.1B 506M Dec/2025
Xoma USD 87.94M 15.5M Sep/2025